Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H14N2O3 |
InChIKeyJNDAHXOWDRYLBK-UHFFFAOYSA-N |
CAS Registry1309925-39-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 16 May 2011 |